Literature DB >> 29907570

The endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls a critical checkpoint in B cell development in mice.

Yi Yang1,2, Sinyi Kong2, Yana Zhang2,3, Johanna Melo-Cardenas2, Beixue Gao2, Yusi Zhang2, Donna D Zhang4, Bin Zhang5, Jianxun Song6, Edward Thorp2, Kezhong Zhang7, Jinping Zhang8, Deyu Fang9.   

Abstract

Humoral immunity involves multiple checkpoints that occur in B cell development, maturation, and activation. The pre-B-cell receptor (pre-BCR) is expressed following the productive recombination of the immunoglobulin heavy-chain gene, and sSignalsing through the pre-BCR are required for the differentiation of pre-B cells into immature B cells. However, the molecular mechanisms controlling the pre-BCR expression and signaling strength remain undefined. Herein, we probed the role of the endoplasmic reticulum-associated, stress-activated E3 ubiquitin ligase HMG-CoA reductase degradation 1 (Hrd1) in B cell differentiation. Using mice with a specific Hrd1 deletion in pro-B cells and subsequent B cell developmental stages, we showed that the E3 ubiquitin ligase Hrd1 governs a critical checkpoint during B cell development. We observed that Hrd1 is required for degradation of the pre-BCR complex during the early stage of B cell development. As a consequence, loss of Hrd1 in the B cell lineage resulted in increased pre-BCR expression levels and a developmental defect in the transition from large to small pre-B cells. This defect, in turn, resulted in reduced fewer mature B cells in bone marrow and peripheral lymphoid organs. Our results revealed a novel critical role of Hrd1 in controlling a critical checkpoint in B cell-mediated immunity and suggest that Hrd1 may functioning as an E3 ubiquitin ligase of the pre-BCR complex.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  lymphocyte; pre-BCR; protein turnover; ubiquitin; ubiquitin ligase; unfolded protein response (UPR)

Mesh:

Substances:

Year:  2018        PMID: 29907570      PMCID: PMC6102136          DOI: 10.1074/jbc.RA117.001267

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  C/EBP-Homologous Protein (CHOP) in Vascular Smooth Muscle Cells Regulates Their Proliferation in Aortic Explants and Atherosclerotic Lesions.

Authors:  Alex-Xianghua Zhou; Xiaobo Wang; Chyuan Sheng Lin; Jaeseok Han; Jing Yong; Marissa J Nadolski; Jan Borén; Randal J Kaufman; Ira Tabas
Journal:  Circ Res       Date:  2015-04-14       Impact factor: 17.367

2.  Chaperone gp96-independent inhibition of endotoxin response by chaperone-based peptide inhibitors.

Authors:  Shuang Wu; Krystal Dole; Feng Hong; Abu Shadat M Noman; Jennifer Issacs; Bei Liu; Zihai Li
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

3.  N-linked glycosylation selectively regulates autonomous precursor BCR function.

Authors:  Rudolf Ubelhart; Martina P Bach; Cathrin Eschbach; Thomas Wossning; Michael Reth; Hassan Jumaa
Journal:  Nat Immunol       Date:  2010-07-11       Impact factor: 25.606

Review 4.  New insights into pre-BCR and BCR signalling with relevance to B cell malignancies.

Authors:  Robert C Rickert
Journal:  Nat Rev Immunol       Date:  2013-08       Impact factor: 53.106

5.  Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene.

Authors:  Michael Schebesta; Peter L Pfeffer; Meinrad Busslinger
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

6.  The Sel1L-Hrd1 Endoplasmic Reticulum-Associated Degradation Complex Manages a Key Checkpoint in B Cell Development.

Authors:  Yewei Ji; Hana Kim; Liu Yang; Haibo Sha; Christopher A Roman; Qiaoming Long; Ling Qi
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

7.  Synoviolin promotes IRE1 ubiquitination and degradation in synovial fibroblasts from mice with collagen-induced arthritis.

Authors:  Beixue Gao; Sang-Myeong Lee; An Chen; Jinping Zhang; Donna D Zhang; Krishnaswamy Kannan; Robert A Ortmann; Deyu Fang
Journal:  EMBO Rep       Date:  2008-03-28       Impact factor: 8.807

8.  FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1.

Authors:  Sang-Myeong Lee; Beixue Gao; Deyu Fang
Journal:  Blood       Date:  2008-01-25       Impact factor: 22.113

9.  A novel mechanism for the autonomous termination of pre-B cell receptor expression via induction of lysosome-associated protein transmembrane 5.

Authors:  Yohei Kawano; Rika Ouchida; Ji-Yang Wang; Soichiro Yoshikawa; Mutsumi Yamamoto; Daisuke Kitamura; Hajime Karasuyama
Journal:  Mol Cell Biol       Date:  2012-09-04       Impact factor: 4.272

10.  Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.

Authors:  Heeyoung Yang; Quan Qiu; Beixue Gao; Sinyi Kong; Zhenghong Lin; Deyu Fang
Journal:  J Exp Med       Date:  2014-11-03       Impact factor: 14.307

View more
  10 in total

1.  The E3 ligase Hrd1 stabilizes Tregs by antagonizing inflammatory cytokine-induced ER stress response.

Authors:  Yuanming Xu; Johanna Melo-Cardenas; Yana Zhang; Isabella Gau; Juncheng Wei; Elena Montauti; Yusi Zhang; Beixue Gao; Hongjian Jin; Zhaolin Sun; Sang-Myeong Lee; Deyu Fang
Journal:  JCI Insight       Date:  2019-03-07

Review 2.  ER-associated degradation in health and disease - from substrate to organism.

Authors:  Asmita Bhattacharya; Ling Qi
Journal:  J Cell Sci       Date:  2019-12-02       Impact factor: 5.285

3.  HRD1-mediated METTL14 degradation regulates m6A mRNA modification to suppress ER proteotoxic liver disease.

Authors:  Juncheng Wei; Bryan T Harada; Dan Lu; Ruihua Ma; Beixue Gao; Yanan Xu; Elena Montauti; Nikita Mani; Shuvam M Chaudhuri; Shana Gregory; Samuel E Weinberg; Donna D Zhang; Richard Green; Chuan He; Deyu Fang
Journal:  Mol Cell       Date:  2021-11-29       Impact factor: 17.970

4.  Cryptotanshinone alleviates myocardial ischemia and reperfusion injury in rats to mitigate ER stress-dependent apoptosis by modulating the JAK1/STAT3 axis.

Authors:  Shasha Wang; Lifang Sun; Zhijian Zhu; Junyi Liu; Wei Ge; Baoyin Li; Bing Wang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

5.  Endoplasmic reticulum-associated degradation regulates mitochondrial dynamics in brown adipocytes.

Authors:  Zhangsen Zhou; Mauricio Torres; Haibo Sha; Christopher J Halbrook; Françoise Van den Bergh; Rachel B Reinert; Tatsuya Yamada; Siwen Wang; Yingying Luo; Allen H Hunter; Chunqing Wang; Thomas H Sanderson; Meilian Liu; Aaron Taylor; Hiromi Sesaki; Costas A Lyssiotis; Jun Wu; Sander Kersten; Daniel A Beard; Ling Qi
Journal:  Science       Date:  2020-03-19       Impact factor: 47.728

Review 6.  How Is the Fidelity of Proteins Ensured in Terms of Both Quality and Quantity at the Endoplasmic Reticulum? Mechanistic Insights into E3 Ubiquitin Ligases.

Authors:  Ji An Kang; Young Joo Jeon
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

7.  SEL1L-HRD1 ER-associated degradation suppresses hepatocyte hyperproliferation and liver cancer.

Authors:  Asmita Bhattacharya; Juncheng Wei; Wenxin Song; Beixue Gao; Chunyan Tian; Shuangcheng Alivia Wu; Jian Wang; Ligong Chen; Deyu Fang; Ling Qi
Journal:  iScience       Date:  2022-09-24

Review 8.  Endoplasmic reticulum-associated degradation and beyond: The multitasking roles for HRD1 in immune regulation and autoimmunity.

Authors:  Yuanming Xu; Deyu Fang
Journal:  J Autoimmun       Date:  2020-02-11       Impact factor: 14.511

Review 9.  Protein Aggregation in the ER: Calm behind the Storm.

Authors:  Haisen Li; Shengyi Sun
Journal:  Cells       Date:  2021-11-28       Impact factor: 7.666

10.  Notch-induced endoplasmic reticulum-associated degradation governs mouse thymocyte β-selection.

Authors:  Xia Liu; Jingjing Yu; Longyong Xu; Katharine Umphred-Wilson; Fanglue Peng; Yao Ding; Brendan M Barton; Xiangdong Lv; Michael Y Zhao; Shengyi Sun; Yuning Hong; Ling Qi; Stanley Adoro; Xi Chen
Journal:  Elife       Date:  2021-07-09       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.